previou
studi
shown
earli
wheez
induc
rhinoviru
andor
associ
sensit
import
risk
factor
recurr
wheez
asthma
like
reveal
underli
airway
inflamm
weak
viral
defens
howev
factor
influenc
bronchial
reactiv
children
poorli
character
previou
studi
shown
factor
famili
histori
matern
exposur
air
preterm
low
birth
may
associ
decreas
pulmonari
function
later
childhood
two
studi
shown
wheez
young
age
induc
rhinoviru
may
associ
decreas
pulmonari
function
increas
airway
reactiv
later
studi
shown
compar
associ
respiratori
syncyti
viru
rsv
wheez
reduc
pulmonari
function
howev
earlier
studi
mainli
includ
older
children
data
first
wheez
episod
pulmonari
function
test
young
children
challeng
impuls
oscillometri
io
method
test
pulmonari
function
tidal
key
measur
io
respiratori
resist
rr
indic
energi
loss
due
resist
forc
airflow
airway
clinic
interpret
indic
obstruct
io
requir
minimum
cooper
success
use
age
year
finland
refer
valu
avail
children
age
secondari
strategi
prevent
asthma
initi
time
first
wheez
howev
known
patient
characterist
time
first
acut
wheez
episod
predict
abnorm
pulmonari
function
later
childhood
thu
among
children
suffer
first
acut
sever
wheez
episod
age
year
aim
determin
pulmonari
function
age
year
reactiv
exercis
bronchodil
io
also
test
factor
predict
exercis
bronchial
reactiv
hypothes
patient
characterist
rhinoviru
etiolog
atopi
time
first
sever
wheez
episod
would
associ
pulmonari
function
increas
bronchial
reactiv
measur
io
year
first
wheez
episod
studi
part
larger
studi
carri
turku
univers
hospit
recruit
june
march
aim
origin
studi
assess
effect
cours
oral
prednisolon
first
dose
mgkg
mgkgday
two
divid
dose
maximum
dose
mgday
mg
tablet
leira
takeda
helsinki
finland
children
first
acut
wheez
episod
hospit
treat
emerg
room
tertiari
hospit
use
random
parallel
design
inclus
criteria
age
month
first
acut
wheez
episod
confirm
parent
report
medic
record
deliveri
week
children
chronic
nonatop
ill
need
intens
care
unit
treatment
previou
system
inhal
corticosteroid
ic
treatment
exclud
studi
studi
approv
ethic
committe
turku
univers
hospit
commenc
obtain
written
inform
consent
guardian
trial
studi
entri
guardian
complet
standard
questionnair
form
child
physic
examin
nasopharyng
aspir
sampl
taken
use
standard
blood
sampl
drawn
studi
drug
initi
nasopharyng
aspir
rhinoviru
pcr
posit
pulmonari
function
evalu
visit
four
year
later
io
jaeger
gmbh
germani
see
detail
guardian
instruct
discontinu
ic
treatment
children
week
visit
studi
protocol
regist
clinicaltrialsgov
august
clinicaltrialsgov
number
studi
entri
multiplex
seeplex
ace
detect
seegen
seoul
korea
singl
pcr
test
use
detect
adenoviru
coronaviru
enterovirus
human
bocaviru
human
metapneumoviru
influenza
b
virus
parainfluenza
viru
type
rhinoviru
type
b
c
rsv
b
depart
virolog
univers
rhinoviru
sequenc
previous
describ
analyz
collabor
univers
human
also
analyz
use
serolog
previous
analyz
viru
genom
load
steril
flock
swab
catalog
number
copan
brescia
itali
first
dip
aspir
dilut
ml
salin
genom
load
analyz
rna
sampl
quantit
use
known
concentr
plasmid
plasmid
receiv
glyn
stanway
univers
colchest
essex
uk
describ
serum
level
immunoglobulin
e
ige
phadiatop
phadia
uppsala
sweden
blood
eosinophil
count
analyz
central
laboratori
turku
univers
hospit
serum
measur
taken
use
liquid
chromatographi
tandem
mass
spectrometri
massachusett
gener
hospit
boston
usa
airway
hyperrespons
revers
airflow
obstruct
measur
use
impuls
oscillatori
signal
hz
use
output
pressur
flow
signal
analyz
amplitud
phase
differ
determin
airway
resist
rr
variabl
reflect
energi
loss
due
resist
forc
airflow
reactanc
xr
indic
viscoelast
properti
small
airway
rr
xr
compon
total
respiratori
imped
zr
result
phase
pressur
chang
airflow
frequenc
depend
resist
drrsdf
determin
use
linear
regress
resist
data
point
obstruct
rr
increas
result
increas
drrsdf
xr
decreas
due
peripher
stiffen
result
obstruct
technic
realiz
io
describ
detail
appendix
baselin
measur
exercis
test
conduct
children
urg
run
min
exercis
level
heart
rate
held
estim
maximum
heart
rate
age
assess
heart
rate
monitor
polar
sport
polar
elektro
ltd
kempel
finland
io
measur
repeat
min
exercis
final
revers
airflow
obstruct
assess
io
min
bronchodil
inhal
microgram
salbutamol
administ
spacer
product
glaxosmithklin
brentford
uk
result
proport
height
child
rr
hz
categor
patholog
chang
mean
crude
valu
chang
mean
crude
valu
malmberg
beydon
children
atop
sensit
posit
test
cutoff
level
kul
ige
specif
test
allergen
codfish
cow
milk
egg
peanut
soybean
wheat
cat
dog
hors
birch
mugwort
timothi
cladosporium
herbarum
dermatophagoid
pteronyssinu
eczema
studi
entri
diagnosi
accord
pruritu
typic
morpholog
chronic
diseas
defin
atop
sensit
diagnos
baselin
differ
group
differ
characterist
analyz
normal
distribut
variabl
u
test
skew
variabl
test
fisher
exact
test
categor
data
result
express
mean
standard
deviat
sd
normal
distribut
median
interquartil
rang
iqr
skew
distribut
number
categor
variabl
normal
variabl
assess
test
natur
logarithm
ln
chang
appli
rr
hz
multivari
regress
analysi
due
posit
skew
distribut
logist
linear
regress
analys
use
multivari
analys
result
logist
regress
analys
express
odd
ratio
confid
interv
ci
result
linear
regress
analys
regress
coeffici
beta
ci
multivari
model
includ
age
oral
corticosteroid
oc
treatment
rhinoviru
studi
entri
depend
depend
variabl
also
atop
sensit
season
sensit
atop
eczema
hospit
studi
entri
andor
ic
within
week
data
analyz
use
ibm
spss
version
spss
inc
chicago
il
usa
statist
power
analysi
conduct
io
outcom
jartti
p
consid
statist
signific
enrol
children
attend
visit
figur
io
bronchodil
test
conduct
children
exercis
test
children
exercis
test
conduct
due
refus
run
two
children
due
sever
asthma
symptom
one
child
children
bronchodil
andor
exercis
test
n
includ
analysi
includ
n
exclud
n
particip
differ
one
anoth
concern
patient
characterist
shown
tabl
tabl
studi
entri
mean
age
studi
subject
month
sd
hospit
children
boy
least
one
viru
found
airway
children
common
viru
rhinoviru
found
children
rsv
found
children
virus
children
least
two
virus
found
airway
children
first
wheez
episod
atop
sensit
aeroallergen
sensit
food
sensit
tabl
visit
mean
age
children
month
sd
month
children
use
ic
treatment
month
preced
visit
asthma
medic
discontinu
week
prior
exercis
test
children
children
use
ic
tabl
baselin
io
measur
one
child
patholog
rr
hz
valu
one
child
patholog
xr
hz
valu
compar
finnish
refer
valu
absolut
io
valu
shown
tabl
children
atop
eczema
ci
p
season
atop
sensit
ci
p
studi
entri
lower
xr
hz
baselin
measur
children
atop
eczema
season
sensit
respect
result
howev
statist
signific
multivari
analys
includ
age
oc
first
wheez
episod
rhinoviru
etiolog
ic
use
week
oscillometri
multivari
analysi
age
studi
entri
acut
wheez
associ
decreas
xr
hz
ci
p
older
age
studi
entri
lower
complianc
lung
tissu
due
small
airway
obstruct
factor
viru
etiolog
shown
tabl
associ
baselin
valu
io
tabl
baselin
rr
valu
associ
factor
shown
tabl
data
shown
increas
bronchial
reactiv
diagnos
children
eight
chang
diagnos
exercis
test
rr
hz
increas
one
children
rr
hz
decreas
follow
administr
salbutamol
increas
bronchial
reactiv
induc
exercis
common
children
atop
eczema
ci
p
atop
sensit
ci
p
time
first
wheez
episod
associ
atop
sensit
ci
p
remain
multivari
analysi
includ
age
studi
entri
oc
first
wheez
episod
atop
sensit
rhinoviru
etiolog
studi
entri
tabl
chang
rr
hz
significantli
greater
children
atop
sensit
studi
entri
ci
p
atop
eczema
studi
entri
ci
p
hospit
studi
entri
ci
p
ic
use
within
week
ci
p
adjust
analysi
includ
age
studi
entri
hospit
oc
use
studi
entri
ic
use
within
week
atop
sensit
studi
entri
rhinoviru
etiolog
atop
sensit
remain
statist
signific
ci
p
chang
postbronchodil
valu
affect
factor
shown
tabl
tabl
postexercis
postbronchodil
rr
valu
affect
factor
shown
tabl
data
shown
statist
signific
differ
bronchial
reactiv
depend
age
sex
viru
etiolog
howev
children
patholog
bronchial
reactiv
rhinoviru
posit
first
wheez
episod
likewis
patient
characterist
shown
tabl
associ
bronchial
reactiv
oc
treatment
first
wheez
episod
affect
pulmonari
function
four
year
later
signific
differ
baselin
io
paramet
p
bronchial
reactiv
p
prednisolon
placebo
group
children
abl
discontinu
ic
use
chang
rr
hz
greater
user
ci
p
associ
remain
adjust
analysi
tabl
tabl
result
without
children
use
continu
ic
treatment
visit
markedli
differ
data
shown
knowledg
first
studi
investig
associ
patient
characterist
first
acut
sever
wheez
episod
subsequ
pulmonari
function
bronchial
reactiv
later
childhood
main
find
atop
sensit
aeroallergen
food
sensit
first
wheez
episod
associ
increas
bronchial
reactiv
preschool
age
find
signific
associ
rhinoviru
genom
load
viru
infect
patient
characterist
studi
entri
later
pulmonari
function
bronchial
reactiv
previou
studi
report
earli
atop
sensit
import
predictor
reduc
pulmonari
function
later
illi
et
first
recogn
pulmonari
function
impair
age
year
children
earlier
atop
wheez
children
earlier
nonatop
wheez
turner
et
demonstr
infant
atopi
associ
reduct
pulmonari
function
measur
rapid
compress
techniqu
spirometri
age
month
year
moreov
belgrav
et
found
number
earli
specif
sensit
correl
invers
pulmonari
function
measur
plethysmographi
age
year
find
extend
result
show
atop
sensit
time
first
sever
wheez
episod
associ
increas
bronchial
reactiv
measur
io
addit
reduct
pulmonari
function
age
year
link
allerg
airway
inflamm
subsequ
increas
bronchial
reactiv
incomplet
understood
possibl
explan
relat
immun
dysregul
promot
type
cytokin
exampl
counteract
mechan
exampl
interferon
express
import
viral
allerg
airway
inflamm
may
also
weaken
epitheli
barrier
function
therebi
increas
suscept
viral
previou
studi
shown
parent
asthma
matern
smoke
associ
baselin
pulmonari
function
andor
bronchial
studi
also
found
associ
patient
characterist
decreas
pulmonari
function
age
vitamin
found
potenti
prevent
infecti
diseas
atop
ill
innat
adapt
immun
studi
patient
characterist
data
care
assembl
level
analyz
howev
find
associ
patient
characterist
io
paramet
associ
rhinoviru
genom
load
pulmonari
function
investig
earlier
find
associ
viral
load
io
paramet
well
studi
mean
age
children
pulmonari
function
test
lower
compar
earlier
studi
mean
year
vs
year
may
partli
explain
neg
result
low
sensit
io
anoth
probabl
explan
neg
result
moreov
first
studi
concentr
first
acut
wheez
episod
thu
result
underlin
role
sensit
earli
risk
marker
later
bronchial
reactiv
earlier
studi
shown
decreas
baselin
pulmonari
function
case
year
studi
proport
patholog
pulmonari
function
baselin
low
detect
rate
bronchial
reactiv
also
rel
low
compar
earlier
studi
studi
twelv
children
abl
discontinu
ic
medic
asthma
may
partli
explain
low
detect
rate
increas
bronchial
reactiv
howev
major
children
use
ic
medic
discontinu
least
four
week
io
test
accord
finnish
line
us
nation
asthma
educ
prevent
program
regular
asthma
control
medic
start
rel
earli
life
although
unproven
may
lead
better
manag
asthma
alreadi
earli
childhood
minor
pulmonari
function
impair
preschool
age
pulmonari
function
measur
young
children
technic
challeng
io
rel
new
method
shown
promis
age
year
onward
due
requir
minimum
success
rate
io
studi
exercis
test
conduct
success
children
support
role
io
prefer
pulmonari
function
test
method
young
children
exercis
test
practic
method
bronchial
reactiv
test
alreadi
children
rr
depend
height
child
frequenc
signal
use
finnish
refer
make
result
reliabl
strength
studi
includ
prospect
design
new
focu
first
wheez
episod
comprehens
viral
diagnost
use
io
pulmonari
function
test
good
qualiti
io
measur
discontinu
regular
asthma
control
medic
major
asthmat
children
test
ige
use
character
atop
sensit
children
care
examin
physician
standard
questionnair
use
provid
detail
character
howev
studi
limit
patient
hospit
first
acut
wheez
episod
make
result
applic
sever
end
ill
rel
small
studi
popul
preclud
analysi
rhinoviru
speci
associ
respiratori
virus
spirometri
outcom
reason
challeng
exercis
test
ensur
continu
heart
rate
monitor
ventil
measur
purpos
conclus
atop
sensit
diagnos
first
acut
sever
wheez
episod
associ
increas
bronchial
reactiv
reduc
lung
function
preschool
age
clinic
result
suggest
test
atop
sensit
time
first
wheez
episod
may
prognost
signific
respect
lung
function
result
also
import
consid
design
earli
intervent
trial
secondari
prevent
asthma
author
conflict
interest
connect
paper
al
ml
rt
tj
collect
studi
data
tyv
yab
jeg
tj
gave
expert
advic
supervis
collect
data
al
analyz
data
prepar
manuscript
tev
gave
advic
supervis
statist
analys
author
activ
contribut
write
edit
evalu
manuscript
author
approv
final
version
manuscript
